Present and future developments in hepatic tissue engineering for liver support systems: State of the art and future developments of hepatic cell culture techniques for the use in liver support systems

Cytotechnology

Volumn 50, Issue 1-3, 2006, Pages 163-179

  Diekmann, Sonja ^a   Bader, Augustinus ^a   Schmitmeier, Stephanie ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Bioartificial liver; Hepatocytes; Liver failure; Liver support systems

Indexed keywords

XENOBIOTIC AGENT;

BIOARTIFICIAL LIVER; CELL CULTURE; DETOXIFICATION; DIALYSIS; FILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER SUPPORT; LIVER TRANSPLANTATION; REVIEW; SURVIVAL RATE; TISSUE ENGINEERING;

EID: 33747359427     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-006-6336-4     Document Type: Review

References (142)

1. Auth M.K., Okamoto M., Ishida Y., Keogh A., Auth S.H., Gerlach J., Encke A., McMaster P. and Strain A.J. 1998. Maintained function of primary human hepatocytes by cellular interactions in coculture: implications for liver support systems. Transpl. Int. 11(Suppl. 1): S439-S443.
2. Babensee J.E., De Boni U. and Sefton M.V. 1992. Morphological assessment of hepatoma cells (HepG2) microencapsulated in a HEMA-MMA copolymer with and without Matrigel. J. Biomed. Mater. Res. 26: 1401-1418.
3. Bader A., Fruhauf N., Zech K., Haverich A. and Borlak J.T. 1998. Development of a small-scale bioreactor for drug metabolism studies maintaining hepatospecific functions. Xenobiotica 28: 815-825.
4. Bader A., Knop E., Kern A., Boker K., Fruhauf N., Crome O., Esselmann H., Pape C., Kempka G. and Sewing K.F. 1996. 3-D coculture of hepatic sinusoidal cells with primary hepatocytes-design of an organotypical model. Exp. Cell Res. 226: 223-233.
5. Bader A., Rinkes I.H., Closs E.I., Ryan C.M., Toner M., Cunningham J.M., Tompkins R.G. and Yarmush M.L. 1992. A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes. Biotechnol. Prog. 8: 219-225.
6. Baquerizo A., Mhoyan A., Kearns-Jonker M., Arnaout W.S., Shackleton C., Busuttil R.W., Demetriou A.A. and Cramer D.V. 1999. Characterization of human xenoreactive antibodies in liver failure patients exposed to pig hepatocytes after bioartificial liver treatment: an ex vivo model of pig to human xenotransplantation. Transplantation 67: 5-18.
7. Ben-Ze'ev A., Robinson G.S., Bucher N.L. and Farmer S.R. 1988. Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary cultures of rat hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 85: 2161-2165.
8. Black D., Lyman S., Heider T.R. and Behrns K.E. 2004. Molecular and cellular features of hepatic regeneration. J. Surg. Res. 117: 306-315.
9. Blusch J.H., Patience C. and Martin U. 2002. Pig endogenous retroviruses and xenotransplantation. Xenotransplantation 9: 242-251.
10. Braet F., Shleper M., Paizi M., Brodsky S., Kopeiko N., Resnick N. and Spira G. 2004. Liver sinusoidal endothelial cell modulation upon resection and shear stress in vitro. Comp. Hepatol. 3: 7.
11. Bucher N.L., Robinson G.S. and Farmer S.R. 1990. Effects of extracellular matrix on hepatocyte growth and gene expression: implications for hepatic regeneration and the repair of liver injury. Semin. Liver Dis. 10: 11-19.
12. Canaple L., Nurdin N., Angelova N., Hunkeler D. and Desvergne B. 2001. Development of a coculture model of encapsulated cells. Ann. NY Acad. Sci. 944: 350-361.
13. Cascio S.M. 2001. Novel strategies for immortalization of human hepatocytes. Artif. Organs 25: 529-538.
14. Costa R.H., Kalinichenko V.V., Holterman A.X. and Wang X. 2003. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38: 1331-1347.
15. Curcio E., De Bartolo L., Barbieri G., Rende M., Giorno L., Morelli S. and Drioli E. 2005. Diffusive and convective transport through hollow fiber membranes for liver cell culture. J. Biotechnol. 117: 309-321.
16. David B., Dore E., Jaffrin M.Y. and Legallais C. 2004. Mass transfers in a fluidized bed bioreactor using alginate beads for a future bioartificial liver. Int. J. Artif. Organs 27: 284-293.
17. De Bartolo L. and Bader A. 2001. Review of a flat membrane bioreactor as a bioartificial liver. Ann. Transplant. 6: 40-46.
18. De Bartolo L., Jarosch-Von Schweder G., Haverich A. and Bader A. 2000. A novel full-scale flat membrane bioreactor utilizing porcine hepatocytes: cell viability and tissue-specific functions. Biotechnol. Prog. 16: 102-108.
19. De Bartolo L., Morelli S., Bader A. and Drioli E. 2002. Evaluation of cell behaviour related to physico-chemical properties of polymeric membranes to be used in bioartificial organs. Biomaterials 23: 2485-2497.
20. De Bartolo L., Morelli S., Lopez L.C., Giorno L., Campana C., Salerno S., Rende M., Favia P., Detomaso L., Gristina R., d'Agostino R. and Drioli E. 2005. Biotransformation and liver-specific functions of human hepatocytes in culture on RGD-immobilized plasma-processed membranes. Biomaterials 26: 4432-4441.
21. De Bartolo L., Morelli S., Rende M., Gordano A. and Drioli E. 2004. New modified polyetheretherketone membrane for liver cell culture in biohybrid systems: adhesion and specific functions of isolated hepatocytes. Biomaterials 25: 3621-3629.
22. De Leeuw A.M., Brouwer A. and Knook D.L. 1990. Sinusoidal endothelial cells of the liver: fine structure and function in relation to age. J. Electron. Microsc. Tech. 14: 218-236.
23. De Vos P., De Haan B. and Van Schilfgaarde R. 1997. Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18: 273-278.
24. Demetriou A.A., Brown R.S., Busuttil R.W., Fair J., McGuire B.M., Rosenthal P., Am Esch J.S., Lerut J., Nyberg S.L., Salizzoni M., Fagan E.A., de Hemptinne B., Broelsch C.E., Muraca M., Salmeron J.M., Rabkin J.M., Metselaar H.J., Pratt D., La Mata M., McChesney L.P., Everson G.T., Lavin P.T., Stevens A.C., Pitkin Z. and Solomon B.A. 2004. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239: 660-667.
25. Dixit V., Darvasi R., Arthur M., Lewin K. and Gitnick G. 1993. Cryopreserved microencapsulated hepatocytes-transplantation studies in Gunn rats. Transplantation 55: 616-622.
26. Dixit V. and Gitnick G. 1998. The bioartificial liver: state-of-the-art. Eur. J. Surg. 582(Suppl.): S71-S76.
27. Dore E. and Legallais C. 1999. A new concept of bioartificial liver based on a fluidized bed bioreactor. Ther. Apher. 3: 264-267.
28. Dou M., de Sousa G., Lacarelle B., Placidi M., la Porte P., Domingo M., Lafont H. and Rahmani R. 1992. Thawed human hepatocytes in primary culture. Cryobiology 29: 454-469.
29. Dunn J.C., Tompkins R.G. and Yarmush M.L. 1991. Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration. Biotechnol. Prog. 7: 237-245.
30. Dunn J.C., Tompkins R.G. and Yarmush M.L. 1992. Hepatocytes in collagen sandwich: evidence for transcriptional and translational regulation. J. Cell Biol. 116: 1043-1053.
31. Dunn J.C., Yarmush M.L., Koebe H.G. and Tompkins R.G. 1989. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. Faseb. J. 3: 174-177.
32. Ellis A.J., Hughes R.D., Wendon J.A., Dunne J., Langley P.G., Kelly J.H., Gislason G.T., Sussman N.L. and Williams R. 1996. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24: 1446-1451.
33. Elvevold K.H., Nedredal G.I., Revhaug A. and Smedsrod B. 2004. Scavenger properties of cultivated pig liver endothelial cells. Comp. Hepatol. 3: 4.
34. Enomoto K., Nishikawa Y., Omori Y., Tokairin T., Yoshida M., Ohi N., Nishimura T., Yamamoto Y. and Li Q. 2004. Cell biology and pathology of liver sinusoidal endothelial cells. Med. Electron. Microsc. 37: 208-215.
35. Eschbach E., Chatterjee S.S., Noldner M., Gottwald E., Dertinger H., Weibezahn K.F. and Knedlitschek G. 2005. Microstructured scaffolds for liver tissue cultures of high cell density: morphological and biochemical characterization of tissue aggregates. J. Cell Biochem. 95: 243-255.
36. Evenepoel P., Laleman W., Wilmer A., Claes K., Maes B., Kuypers D., Bammens B., Nevens F. and Vanrenterghem Y. 2005. Detoxifying capacity and kinetics of prometheus - a new extracorporeal system for the treatment of liver failure. Blood Purif. 23: 349-358.
37. Fishman J.A. and Patience C. 2004. Xenotransplantation: infectious risk revisited. Am. J. Transplant. 4: 1383-1390.
38. Flendrig L.M., Calise F., Di Florio E., Mancini A., Ceriello A., Santaniello W., Mezza E., Sicoli F., Belleza G., Bracco A., Cozzolino S., Scala D., Mazzone M., Fattore M., Gonzales E. and Chamuleau R.A. 1999. Significantly improved survival time in pigs with complete liver ischemia treated with a novel bioartificial liver. Int. J. Artif. Organs 22: 701-709.
39. Flendrig L.M., la Soe J.W., Jorning G.G., Steenbeek A., Karlsen O.T., Bovee W.M., Ladiges N.C., te Velde A.A. and Chamuleau R.A. 1997. In vitro evaluation of a novel bioreactor based on an integral oxygenator and a spirally wound nonwoven polyester matrix for hepatocyte culture as small aggregates. J. Hepatol. 26: 1379-1392.
40. Fremond B., Malandain C., Guyomard C., Chesne C., Guillouzo A. and Campion J.P. 1993. Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads as an extracorporeal bioartificial liver. Cell Transplant. 2: 453-460.
41. Fruhauf N.R., Oldhafer K.J., Holtje M., Kaiser G.M., Fruhauf J.H., Stavrou G.A., Bader A. and Broelsch C.E. 2004. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model. Surgery 136: 47-56.
42. Gan J.H., Zhou X.Q., Qin A.L., Luo E.P., Zhao W.F., Yu H. and Xu J. 2005. Hybrid artificial liver support system for treatment of severe liver failure. World J. Gastroenterol. 11: 890-894.
43. Gerlach J.C. 1996. Development of a hybrid liver support system: a review. Int. J. Artif. Organs 19: 645-654.
44. Gerlach J.C., Kloppel K., Muller C., Schnoy N., Smith M.D. and Neuhaus P. 1993. Hepatocyte aggregate culture technique for bioreactors in hybrid liver support systems. Int. J. Artif. Organs 16: 843-846.
45. Gerlach J.C., Mutig K., Sauer I.M., Schrade P., Efimova E., Mieder T., Naumann G., Grunwald A., Pless G., Mas A., Bachmann S., Neuhaus P. and Zeilinger K. 2003. Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study. Transplantation 76: 781-786.
46. Gimson A.E. 1996. Fulminant and late onset hepatic failure. Br. J. Anaesth. 77: 90-98.
47. Glicklis R., Merchuk J.C. and Cohen S. 2004. Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol. Bioeng. 86: 672-680.
48. Glicklis R., Shapiro L., Agbaria R., Merchuk J.C. and Cohen S. 2000. Hepatocyte behavior within three-dimensional porous alginate scaffolds. Biotechnol. Bioeng. 67: 344-353.
49. Gregory P.G., Connolly C.K., Toner M. and Sullivan S.J. 2000. In vitro characterization of porcine hepatocyte function. Cell Transplant. 9: 1-10.
50. Guillouzo A., Rialland L., Fautrel A. and Guyomard C. 1999. Survival and function of isolated hepatocytes after cryopreservation. Chem. Biol. Interact. 121: 7-16.
51. Hasegawa H., Shimada M., Gion T., Ijima H., Nakazawa K., Funatsu K. and Sugimachi K. 1999. Modulation of immunologic reactions between cultured porcine hepatocytes and human sera. ASAIO J. 45: 392-396.
52. He Z.P., Tan W.Q., Tang Y.F. and Feng M.F. 2003. Differentiation of putative hepatic stem cells derived from adult rats into mature hepatocytes in the presence of epidermal growth factor and hepatocyte growth factor. Differentiation 71: 281-290.
53. Hengstler J.G., Ringel M., Biefang K., Hammel S., Milbert U., Gerl M., Klebach M., Diener B., Platt K.L., Bottger T., Steinberg P. and Oesch F. 2000. Cultures with cryopreserved hepatocytes: applicability for studies of enzyme induction. Chem. Biol. Interact. 125: 51-73.
54. Hoekstra R. and Chamuleau R.A. 2002. Recent developments on human cell lines for the bioartificial liver. Int. J. Artif. Organs 25: 182-191.
55. Honiger J., Sarkis R., Baudrimont M., Delelo R., Chafai N., Benoist S., Sarkis K., Balladur P., Capeau J. and Nordlinger B. 2000. Semiautomatic macroencapsulation of large numbers of porcine hepatocytes by coextrusion with a solution of AN69 polymer. Biomaterials 21: 1269-1274.
56. Hughes R.D., Nicolaou N., Langley P.G., Ellis A.J., Wendon J.A. and Williams R. 1998. Plasma cytokine levels and coagulation and complement activation during use of the extracorporeal liver assist device in acute liver failure. Artif. Organs 22: 854-858.
57. Irgang M., Sauer I.M., Karlas A., Zeilinger K., Gerlach J.C., Kurth R., Neuhaus P. and Denner J. 2003. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J. Clin. Virol. 28: 141-154.
58. Isom H.C., Secott T., Georgoff I., Woodworth C. and Mummaw J. 1985. Maintenance of differentiated rat hepatocytes in primary culture. Proc. Natl. Acad. Sci. U.S.A. 82: 3252-3256.
59. Jasmund I., Langsch A., Simmoteit R. and Bader A. 2002. Cultivation of primary porcine hepatocytes in an OXY-HFB for use as a bioartificial liver device. Biotechnol. Prog. 18: 839-846.
60. Jauregui H.O., Mullon C.J., Trenkler D., Naik S., Santangini H., Press P., Muller T.E. and Solomon B.A. 1995. In vivo evaluation of a hollow fiber liver assist device. Hepatology 21: 460-469.
61. Jauregui H.O., Naik S., Santangini H., Pan J., Trenkler D. and Mullon C. 1994. Primary cultures of rat hepatocytes in hollow fiber chambers. In Vitro Cell Dev Biol. Anim. 30: 23-29.
62. Joly A., Desjardins J.F., Fremond B., Desille M., Campion J.P., Malledant Y., Lebreton Y., Semana G., Edwards-Levy F., Levy M.C. and Clement B. 1997. Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: a step toward a reliable bioartificial liver. Transplantation 63: 795-803.
63. Kang Y.H., Berthiaume F., Nath B.D. and Yarmush M.L. 2004. Growth factors and nonparenchymal cell conditioned media induce mitogenic responses in stable long-term adult rat hepatocyte cultures. Exp. Cell Res. 293: 239-247.
64. King A., Strand B., Rokstad A.M., Kulseng B., Andersson A., Skjak-Braek G. and Sandler S. 2003. Improvement of the biocompatibility of alginate/poly-L-lysine/alginate microcapsules by the use of epimerized alginate as a coating. J. Biomed. Mater. Res. (Part) A. 64: 533-539.
65. Kjaergard L.L., Liu J., Als-Nielsen B. and Gluud C. 2003. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 289: 217-222.
66. Kmieć Z. 2001. Cooperation of liver cells in health and disease. In: Beck F., Christ B., Kriz W., Kummer W., Marani E., Putz R., Sano Y., Schiebler T.H., Schoenwolf G.C. and Zilles K. (eds), Advances in Anatomy Embryology and Cell Biology, Vol. 161. Springer-Verlag, Berlin, Heidelberg, New York, pp. 1-149.
67. Kobayashi N., Okitsu T., Nakaji S. and Tanaka N. 2003. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J. Artif. Organs 6: 236-244.
68. Koide N., Sakaguchi K., Koide Y., Asano K., Kawaguchi M., Matsushima H., Takenami T., Shinji T., Mori M. and Tsuji T. 1990. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp. Cell Res. 186: 227-235.
69. Koniaris L.G., McKillop I.H., Schwartz S.I. and Zimmers T.A. 2003. Liver regeneration. J. Am. Coll. Surg. 197: 634-659.
70. Krisper P., Haditsch B., Stauber R., Jung A., Stadlbauer V., Trauner M., Holzer H. and Schneditz D. 2005. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. J. Hepatol. 43: 451-457.
71. Kuddus R., Patzer J.F., Lopez R., Mazariegos G.V., Meighen B., Kramer D.J. and Rao A.S. 2002. Clinical and laboratory evaluation of the safety of a bioartificial liver assist device for potential transmission of porcine endogenous retrovirus. Transplantation 73: 420-429.
72. Lacik I., Brissova M., Anilkumar A.V., Powers A.C. and Wang T. 1998. New capsule with tailored properties for the encapsulation of living cells. J. Biomed. Mater. Res. 39: 52-60.
73. Langsch A. and Bader A. 2001. Longterm stability of phase I and phase II enzymes of porcine liver cells in flat membrane bioreactors. Biotechnol. Bioeng. 76: 115-125.
74. Lee K.W., Park J.B., Yoon J.J., Lee J.H., Kim S.Y., Jung H.J., Lee S.K., Kim S.J., Lee H.H., Lee D.S. and Joh J.W. 2004. The viability and function of cryopreserved hepatocyte spheroids with different cryopreservation solutions. Transplant. Proc. 36: 2462-2463.
75. Lee W.M. 1993.Acute liver failure. N. Engl. J. Med. 329: 1862-1872.
76. Legallais C., Dore E. and Paullier P. 2000. Design of a fluidized bed bioartificial liver. Artif. Organs 24: 519-525.
77. Lorenti A., Barbich M., de Santibanes M., Ielpi M., Vazquez J.C., Sorroche P. and Argibay P. 2003. Ammonium detoxification performed by porcine hepatocyte spheroids in a bioartificial liver for pediatric use: preliminary report. Artif. Organs 27: 665-670.
78. Louha M., Poussin K., Ganne N., Zylberberg H., Nalpas B., Nicolet J., Capron F., Soubrane O., Vons C., Pol S., Beaugrand M, Berthelot P., Franco D., Trinchet J.C., Brechot C. and Paterlini P. 1997. Spontaneous and iatrogenic spreading of liver-derived cells into peripheral blood of patients with primary liver cancer. Hepatology 26: 998-1005.
79. Lowes K.N., Croager E.J., Olynyk J.K., Abraham L.J. and Yeoh G.C. 2003. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J. Gastroenterol. Hepatol. 18: 4-12.
80. Mai G., Huy N.T., Morel P., Mei J., Bosco D., Berney T., Majno P., Mentha G., Trono D. and Buhler L.H. 2005. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Transplant. Proc. 37: 527-529.
81. Martinez-Hernandez A. and Amenta P.S. 1993. The hepatic extracellular matrix. I. Components and distribution in normal liver. Virchows Arch. A. Pathol. Anat. Histopathol. 423: 1-11.
82. Matsushita T., Yagi T., Hardin J.A., Cragun J.D., Crow F.W., Bergen H.R., Gores G.J. and Nyberg S.L. 2003. Apoptotic cell death and function of cryopreserved porcine hepatocytes in a bioartificial liver. Cell Transplant. 12: 109-121.
83. Mazariegos G.V., Kramer D.J., Lopez R.C., Shakil A.O., Rosenbloom A.J., DeVera M., Giraldo M., Grogan T.A., Zhu Y., Fulmer M.L., Amiot B.P. and Patzer J.F. 2001. Safety observations in phase I clinical evaluation of the Excorp Medical Bioartificial Liver Support System after the first four patients. ASAIO J. 47: 471-475.
84. McClelland R.E., MacDonald J.M. and Coger R.N. 2003. Modeling O2 transport within engineered hepatic devices. Biotechnol. Bioeng. 82: 12-27.
85. McLaughlin B.E., Tosone C.M., Custer L.M. and Mullon C. 1999. Overview of extracorporeal liver support systems and clinical results. Ann. NY Acad. Sci. 875: 310-325.
86. Michalopoulos G.K., Bowen W.C., Mule K. and Stolz D.B. 2001. Histological organization in hepatocyte organoid cultures. Am. J. Pathol. 159: 1877-1887.
87. Michalopoulos G.K. and DeFrances M.C. 1997. Liver regeneration. Science 276: 60-66.
88. Mitzner S.R., Stange J., Klammt S., Peszynski P. and Schmidt R. 2001. Albumin dialysis using the molecular adsorbent recirculating system. Curr. Opin. Nephrol. Hypertens. 10: 777-783.
89. Miura Y., Akimoto T. and Yagi K. 1988. Liver functions in hepatocytes entrapped within calcium alginate. Ann. NY Acad. Sci. 542: 521-532.
90. Morsiani E., Brogli M., Galavotti D., Bellini T., Ricci D., Pazzi P. and Puviani A.C. 2001. Long-term expression of highly differentiated functions by isolated porcine hepatocytes perfused in a radial-flow bioreactor. Artif. Organs 25: 740-748.
91. Morsiani E., Brogli M., Galavotti D., Pazzi P., Puviani A.C. and Azzena G.F. 2002a. Biologic liver support: optimal cell source and mass. Int. J. Artif. Organs 25: 985-993.
92. Morsiani E., Pazzi P., Puviani A.C., Brogli M., Valieri L., Gorini P., Scoletta P., Marangoni E., Ragazzi R., Azzena G., Frazzoli E., Di Luca D. and Cassai E. 2002b. Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients. Int. J. Artif. Organs 25: 192-202.
93. Muraca M., Vilei M.T., Zanusso E., Ferraresso C., Granato A., Doninsegna S., Dal Monte R., Carraro P. and Carturan G. 2000. Encapsulation of hepatocytes by SiO(2). Transplant Proc. 32: 2713-2714.
94. Muto Y., Nouri-Aria K.T., Meager A., Alexander G.J., Eddleston A.L. and Williams R. 1988. Enhanced tumour necrosis factor and interleukin-1 in fulminant hepatic failure. Lancet 2: 72-74.
95. Nagy A. 2000. Cre recombinase: the universal reagent for genome tailoring. Genesis 26: 99-109.
96. Nyberg S.L., Hibbs J.R., Hardin J.A., Germer J.J. and Persing D.H. 1999. Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. Transplantation 67: 1251-1255.
97. Nyberg S.L., Mann H.J., Hu M.Y., Payne W.D., Hu W.S., Cerra F.B. and Remmel R.P. 1996. Extrahepatic metabolism of 4-methylumbelliferone and lidocaine in the anhepatic rabbit. Drug Metab. Dispos. 24: 643-648.
98. Nyberg S.L., Platt J.L., Shirabe K., Payne W.D., Hu W.S. and Cerra F.B. 1992a. Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J. 38: M463-M467.
99. Nyberg S.L., Shatford R.A., Hu W.S., Payne W.D. and Cerra F.B. 1992b. Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support). Crit. Care Med. 20: 1157-1168.
100. Nyberg S.L., Shatford R.A., Payne W.D., Hu W.S. and Cerra F.B. 1992c. Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels. Cytotechnology 10: 205-215.
101. Nyberg S.L., Shirabe K., Peshwa M.V., Sielaff T.D., Crotty P.L., Mann H.J., Remmel R.P., Payne W.D., Hu W.S. and Cerra F.B. 1993. Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant. 2: 441-452.
102. Orive G., Hernandez R.M., Gascon A.R., Calafiore R., Chang T.M., De Vos P., Hortelano G., Hunkeler D., Lacik I., Shapiro A.M. and Pedraz J.L. 2003. Cell encapsulation: promise and progress. Nat. Med. 9: 104-107.
103. Orive G., Hernandez R.M., Rodriguez Gascon A., Calafiore R., Chang T.M., de Vos P., Hortelano G., Hunkeler D., Lacik I. and Pedraz J.L 2004. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol. 22: 87-92.
104. Pahernik S.A., Thasler W.E., Doser M., Gomez-Lechon M.J., Castell M.J., Planck H. and Koebe H.G. 2001. High density culturing of porcine hepatocytes immobilized on nonwoven polyurethane-based biomatrices. Cells Tissues Organs 168: 170-177.
105. Pitkin Z. and Mullon C. 1999. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif. Organs 23: 829-833.
106. Quek C.H., Li J., Sun T., Chan M.L., Mao H.Q., Gan L.M., Leong K.W. and Yu H. 2004. Photo-crosslinkable microcapsules formed by polyelectrolyte copolymer and modified collagen for rat hepatocyte encapsulation. Biomaterials 25: 3531-3540.
107. Rahman T. and Hodgson H. 2001. Clinical management of acute hepatic failure. Intensive Care Med. 27: 467-476.
108. Ramadori G. and Armbrust T. 2001. Cytokines in the liver. Eur. J. Gastroenterol. Hepatol. 13: 777-784.
109. Rifai K., Bahr M., Schneider A., Ott M. and Mann M. 2003. Neue Verfahren in der Leberersatztherapie. Medizinische Klinik 98: 750-753.
110. Runge D., Runge D.M., Jager D., Lubecki K.A., Beer Stolz D., Karathanasis S., Kietzmann T., Strom S.C., Jungermann K., Fleig W.E. and Michalopoulos G.K. 2000. Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem. Biophys. Res. Commun. 269: 46-53.
111. Saad B., Scholl F.A., Thomas H., Schawalder H., Streit V., Waechter F. and Maier P. 1993. Crude liver membrane fractions and extracellular matrix components as substrata regulate differentially the preservation and inducibility of cytochrome P-450 isoenzymes in cultured rat hepatocytes. Eur. J. Biochem. 213: 805-814.
112. Sakai Y., Naruse K., Nagashima I., Muto T. and Suzuki M. 1996. Large-scale preparation and function of porcine hepatocyte spheroids. Int. J. Artif. Organs 19: 294-301.
113. Sato Y., Tsukada K. and Hatakeyama K. 1999. Role of shear stress and immune responses in liver regeneration after a partial hepatectomy. Surg. Today 29: 1-9.
114. Sauer I.M. and Gerlach J.C. 2002. Modular extracorporeal liver support. Artif. Organs 26: 703-706.
115. Sauer I.M., Kardassis D., Zeillinger K., Pascher A., Gruenwald A., Pless G., Irgang M., Kraemer M., Puhl G., Frank J., Muller A.R., Steinmuller T., Denner J., Neuhaus P. and Gerlach J.C. 2003. Clinical extracorporeal hybrid liver support-phase I study with primary porcine liver cells. Xenotransplantation 10: 460-469.
116. Sauer I.M., Obermeyer N., Kardassis D., Theruvath T. and Gerlach J.C. 2001. Development of a hybrid liver support system. Ann. NY Acad. Sci. 944: 308-319.
117. Sauer I.M., Zeilinger K., Obermayer N., Pless G., Grunwald A., Pascher A., Mieder T., Roth S., Goetz M., Kardassis D., Mas A., Neuhaus P. and Gerlach J.C. 2002. Primary human liver cells as source for modular extracorporeal liver support-a preliminary report. Int. J. Artif. Organs 25: 1001-1005.
118. Schoen J.M., Wang H.H., Minuk G.Y. and Lautt W.W. 2001. Shear stress-induced nitric oxide release triggers the liver regeneration cascade. Nitric Oxide 5: 453-464.
119. Schuetz E.G., Li D., Omiecinski C.J., Muller-Eberhard U., Kleinman H.K., Elswick B. and Guzelian P.S. 1988. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix. J. Cell Physiol. 134: 309-323.
120. Semino C.E., Merok J.R., Crane G.G., Panagiotakos G. and Zhang S. 2003. Functional differentiation of hepatocyte-like spheroid structures from putative liver progenitor cells in three-dimensional peptide scaffolds. Differentiation 71: 262-270.
121. Seo S.J., Akaike T., Choi Y.J., Shirakawa M., Kang I.K. and Cho C.S. 2005. Alginate microcapsules prepared with xyloglucan as a synthetic extracellular matrix for hepatocyte attachment. Biomaterials 26: 3607-3615.
122. Serandour A.L., Loyer P., Garnier D., Courselaud B., Theret N., Glaise D., Guguen-Guillouzo C. and Corlu A. 2005. TNFa-mediated extracellular matrix remodeling is required for multiple division cycles in rat hepatocytes. Hepatology 41: 478-486.
123. Shito M., Tilles A.W., Tompkins R.G., Yarmush M.L. and Toner M. 2003. Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure. J. Surg. Res. 111: 53-62.
124. Sielaff T.D., Hu M.Y., Rao S., Groehler K., Olson D., Mann H.J., Remmel R.P., Shatford R.A., Amiot B. and Hu W.S. et al. 1995. A technique for porcine hepatocyte harvest and description of differentiated metabolic functions in static culture. Transplantation 59: 1459-1463.
125. Stange J. and Mitzner S. 1996. Hepatocyte encapsulation-initial intentions and new aspects for its use in bioartificial liver support. Int. J. Artif. Organs 19: 45-48.
126. Sussman N.L., Chong M.G., Koussayer T., He D.E., Shang T.A., Whisennand H.H. and Kelly J.H. 1992. Reversal of fulminant hepatic failure using an extracorporeal liver assist device. Hepatology 16: 60-65.
127. Sussman N.L. and Kelly J.H. 1993. Improved liver function following treatment with an extracorporeal liver assist device. Artif. Organs 17: 27-30.
128. Suzuki A., Iwama A., Miyashita H., Nakauchi H. and Taniguchi H. 2003. Role for growth factors and extracellular matrix in controlling differentiation of prospectively isolated hepatic stem cells. Development 130: 2513-2524.
129. Taub R. 2004. Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 5: 836-847.
130. te Velde A.A., Ladiges N.C., Flendrig L.M. and Chamuleau R.A. 1995. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implication for application of pig hepatocytes in a bioartificial liver. J. Hepatol. 23: 184-192.
131. Tong J.Z., Sarrazin S., Cassio D., Gauthier F. and Alvarez F. 1994. Application of spheroid culture to human hepatocytes and maintenance of their differentiation. Biol. Cell 81: 77-81.
132. Tsiaoussis J., Newsome P.N., Nelson L.J., Hayes P.C. and Plevris J.N. 2001. Which hepatocyte will it be? Hepatocyte choice for bioartificial liver support systems. Liver Transpl. 7: 2-10.
133. Uludag H., De Vos P. and Tresco P.A. 2000. Technology of mammalian cell encapsulation. Adv. Drug Deliv. Rev. 42: 29-64.
134. van de Kerkhove M.P., Germans M.R., Deurholt T., Hoekstra R., Joziasse D.H., van Wijk A.C., van Gulik T.M., Chamuleau R.A. and Roos A. 2005a. Evidence for Gala (1-3)Gal expression on primary porcine hepatocytes: implications for bioartificial liver systems. J. Hepatol. 42: 541-547.
135. van de Kerkhove M.P., Hoekstra R., Chamuleau R.A. and van Gulik T.M. 2004. Clinical application of bioartificial liver support systems. Ann. Surg. 240: 216-230.
136. van de Kerkhove M.P., Poyck P.P., Deurholt T., Hoekstra R., Chamuleau R.A. and van Gulik T.M. 2005b. Liver support therapy: an overview of the AMC-bioartificial liver research. Dig. Surg. 22: 254-264.
137. Wake K. 1999. Cell-cell organization and functions of 'sinusoids' in liver microcirculation system. J. Electron. Microsc. (Tokyo) 48: 89-98.
138. Werner A., Duvar S., Muthing J., Buntemeyer H., Kahmann U., Lunsdorf H. and Lehmann J. 1999. Cultivation and characterization of a new immortalized human hepatocyte cell line, HepZ, for use in an artificial liver support system. Ann. NY Acad. Sci. 875: 364-368.
139. Wilkening S., Stahl F. and Bader A. 2003. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab. Dispos. 31: 1035-1042.
140. Xu J., Ma M. and Purcell W.M. 2003. Biochemical and functional changes of rat liver spheroids during spheroid formation and maintenance in culture: II. nitric oxide synthesis and related changes. J. Cell Biochem. 90: 1176-1185.
141. Yamada K., Kamihira M. and Iijima S. 2001. Self-organization of liver constitutive cells mediated by artificial matrix and improvement of liver functions in long-term culture. Biochem. Eng. J. 8: 135-143.
142. Yamashita Y., Shimada M., Tsujita E., Shirabe K., Ijima H., Nakazawa K., Sakiyama R., Fukuda J., Funatsu K. and Sugimachi K. 2003. Efficacy of a larger version of the hybrid artificial liver support system using a polyurethane foam/spheroid packed-bed module in a warm ischemic liver failure pig model for preclinical experiments. Cell Transplant. 12: 101-107.